02
Apr
Ennaid Therapeutics Announces Development of ENU200, A New Antiviral Therapeutic for the Treatment of COVID-19
ENU200 has demonstrated specific antiviral activity against two SARS-CoV-2 proteins, S glycoprotein and Mpro ALPHARETTA, Ga., April 2, 2020 /PRNewswire/ -- Ennaid Therapeutics, LLC,...